You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 60 Issue 6

December 2005

Volume 60, Issue 6

Pages 581–695

  1. Editors’ view

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
  2. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
      Physiologically based pharmacokinetic modelling of the three-step metabolism of pyrimidine using 13C-uracil as an in vivo probe (pages 584–593)

      Suminobu Ito, Takeshi Kawamura, Makoto Inada, Yoshiharu Inoue, Yukihiro Hirao, Toshihisa Koga, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02472.x

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Vasodilator effects of the endothelin ETA receptor selective antagonist BMS-193884 in healthy men (pages 611–622)

      Neeraj Dhaun, Fiona E. Strachan, David E. Newby, Neil R. Johnston, Neville F. Ford, Janis L. Hammett, Maria Palmisano and David J. Webb

      Article first published online: 27 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02503.x

  3. Pharmacogenetics

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
      Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid (pages 623–628)

      Martijn G. H. Van Oijen, Sylvie Huybers, Wilbert H. M. Peters, Joost P. H. Drenth, Robert J. F. Laheij, Freek W. A. Verheugt and Jan B. M. J. Jansen

      Article first published online: 27 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02495.x

    2. You have free access to this content
      Gender specific association of CYP2C9*3 with hyperlipidaemia in Chinese (pages 629–631)

      Chen-Hui Luo, An Wang, Rong-Hua Zhu, Wei-Xia Zhang, Wei Mo, Bang-Ning Yu, Guo-Lin Chen, Dong-Sheng Ou-Yang, Xiao-Hong Duan, A. M. Abd El-Aty and Hong-Hao Zhou

      Article first published online: 13 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02498.x

  4. Drug Disposition

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
      Sulphation of o-desmethylnaproxen and related compounds by human cytosolic sulfotransferases (pages 632–640)

      Charles N. Falany, Peter Ström and Stellan Swedmark

      Article first published online: 27 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02506.x

  5. Pharmacoepidemiology

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
      Dramatic change in prescribing of hormone replacement therapy in the Netherlands after publication of the Million Women Study: a follow-up study (pages 641–647)

      Adrianne Faber, Marcel L. Bouvy, Linda Loskamp, Paul B. Van De Berg, Toine C. G. Egberts and Lolkje T. W. De Jong-van den Berg

      Article first published online: 27 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02502.x

  6. Therapeutics

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
      Usage of paracetamol-containing combination analgesics remains high in primary care (pages 648–652)

      Cara Usher, Mary Teeling, Kathleen Bennett, Bernie McGowan and John Feely

      Article first published online: 13 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02500.x

  7. Adverse drug effects

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
      Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital (pages 653–658)

      A. Vallano, G. Cereza, C. Pedròs, A. Agustí, I. Danés, C. Aguilera and J. M. Arnau

      Article first published online: 27 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02504.x

  8. Short report

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
      Effects of grapefruit juice on the pharmacokinetics of acebutolol (pages 659–663)

      Jari J. Lilja, Kari Raaska and Pertti J. Neuvonen

      Article first published online: 11 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02489.x

  9. Letters to the editors

    1. Top of page
    2. Editors’ view
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacogenetics
    5. Drug Disposition
    6. Pharmacoepidemiology
    7. Therapeutics
    8. Adverse drug effects
    9. Short report
    10. Letters to the editors
    1. You have free access to this content
    2. You have free access to this content
      Interstitial pneumonitis during lamotrigine therapy (pages 666–667)

      Narayanamoorti Saravanan, Olayiwala Musibay Otaiku and Robert Namushi Namushi

      Article first published online: 13 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02493.x

    3. You have free access to this content
      Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial (page 668)

      Dexter Y.L. Leung, Yolanda Y.Y. Kwong and Dennis S.C. Lam

      Article first published online: 13 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02496.x

    4. You have free access to this content
      Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial (page 669)

      Rana Altan-Yaycioglu, Ozgur Yaycioglu and Yonca A. Akova

      Article first published online: 13 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02497.x

    5. You have free access to this content
    6. You have free access to this content
      Subject index (pages 690–691)

      Article first published online: 21 NOV 2005 | DOI: 10.1111/j.1365-2125.2005.02558.x

    7. You have free access to this content
      Author index (pages 684–689)

      Article first published online: 21 NOV 2005 | DOI: 10.1111/j.1365-2125.2005.02557.x

    8. You have free access to this content
      Reviewers for 2005 (pages 692–695)

      Article first published online: 21 NOV 2005 | DOI: 10.1111/j.1365-2125.2005.02561.x

SEARCH

SEARCH BY CITATION